Cullen Capital Management »

Biosante Pharmaceuticals shares owned by Cullen Capital Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Cullen Capital Management from 13F filings

Historical chart of Cullen Capital Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Cullen Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Cullen Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $355k 6.1k 58.06
2023-06-30 $669k 12k 53.83
2023-03-31 $405k 10k 39.72
2022-09-30 $441k 14k 32.17
2022-06-30 $315k 11k 29.65